13D Filing: Ventech Capital II and Eyegate Pharmaceuticals Inc (EYEG)

Page 11 of 11

Page 11 of 11 – SEC Filing

CUSIP No. 30233M 107 13D Page 11 of 11

SIGNATURES

After reasonable inquiry and to the best
of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete
and correct.

FCPR Ventech A
 
By: /s/ Jean Bourcereau  
Jean Bourcereau, Director
FCPR Ventech B
 
By: /s/ Jean Bourcereau  
Jean Bourcereau, Director
FCPR Ventech Coinvest
 
By: /s/ Jean Bourcereau  
Jean Bourcereau, Director
FCPR Ventech Capital II
 
By: /s/ Jean Bourcereau  
Jean Bourcereau, Director
/s/ Alain Caffi  
Alain Caffi  
 
/s/ Jean Bourcereau  
Jean Bourcereau

 

Follow Kiora Pharmaceuticals Inc (NASDAQ:KPRX)

Page 11 of 11